Suppr超能文献

通过生物监测评估风险。

Assessment of risk by biological monitoring.

作者信息

Gompertz D

出版信息

Br J Ind Med. 1981 May;38(2):198-201. doi: 10.1136/oem.38.2.198.

Abstract

Variability between workers is reflected in differences in uptake, metabolism, and excretion of toxic substances, and thus individual response to toxic hazards. It is argued that biological monitoring takes account of these differences enabling individual risk assessments to be made. Risk, however, must be seen in terms of clinical and pathological changes-that is, estimated from morbidity and mortality rates-and so laboratory measurements need to be linked to epidemiological studies before they can be used to indicate acceptable or unacceptable uptake of toxic materials.

摘要

工人之间的差异体现在有毒物质的吸收、代谢和排泄的不同上,进而反映在个体对有毒危害的反应上。有人认为生物监测考虑到了这些差异,从而能够进行个体风险评估。然而,风险必须从临床和病理变化的角度来看待,也就是说,要根据发病率和死亡率来估计,因此在实验室测量结果能够用于表明有毒物质的摄入是否可接受之前,需要将其与流行病学研究联系起来。

相似文献

1
Assessment of risk by biological monitoring.通过生物监测评估风险。
Br J Ind Med. 1981 May;38(2):198-201. doi: 10.1136/oem.38.2.198.
2
Polymorphism in drug metabolism--implications for drug toxicity.
Arch Toxicol Suppl. 1986;9:138-46. doi: 10.1007/978-3-642-71248-7_16.
3
Trends in human risk assessment of pharmaceuticals.药品人体风险评估的趋势。
Anal Bioanal Chem. 2007 Feb;387(4):1167-72. doi: 10.1007/s00216-006-0961-9. Epub 2007 Jan 5.
5
In response: governmental perspective.回应:政府视角。
Environ Toxicol Chem. 2014 Sep;33(9):1918-20. doi: 10.1002/etc.2668.
8
Pharmaceuticals in the environment--a human risk?环境中的药物——对人类有风险吗?
Regul Toxicol Pharmacol. 1998 Dec;28(3):212-21. doi: 10.1006/rtph.1998.1253.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验